Could this pill slow Parkinson's? new trial results are in
Disease control
Completed
This study tested an experimental drug called vutiglabridin in 99 people with early Parkinson's disease. Participants took either the drug or a placebo daily for 24 weeks. Researchers measured changes in movement, daily function, and safety to see if the drug could help control t…
Phase: PHASE2 • Sponsor: Glaceum • Aim: Disease control
Last updated May 26, 2026 10:44 UTC